Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
2
29%
Ph phase_3
1
14%
Ph phase_1
4
57%

Phase Distribution

4

Early Stage

2

Mid Stage

1

Late Stage

Phase Distribution7 total trials
Phase 1Safety & dosage
4(57.1%)
Phase 2Efficacy & side effects
2(28.6%)
Phase 3Large-scale testing
1(14.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

7

all time

Status Distribution
Completed(3)
Other(4)

Detailed Status

unknown4
Completed3

Development Timeline

Analytics

Development Status

Total Trials
7
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 14 (57.1%)
Phase 22 (28.6%)
Phase 31 (14.3%)

Trials by Status

completed343%
unknown457%

Recent Activity

0 active trials
Showing 5 of 7
unknownphase_2

ZD0473 in Treating Patients With Progressive or Relapsed Non-Small Lung Cancer

NCT00021008
completedphase_1

ZD0473 and Doxorubicin in Treating Patients With Advanced Solid Tumors or Lymphoma

NCT00016172
unknownphase_1

Cardiac Safety Assessment Study of Picoplatin in Solid Tumors

NCT00710697
completedphase_1

A Study Comparing Oral Picoplatin With Intravenous Picoplatin in Subjects With Solid Tumors

NCT00465725
unknownphase_3

Study of Picoplatin Efficacy After Relapse

NCT00465491
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT00021008Phase 2

ZD0473 in Treating Patients With Progressive or Relapsed Non-Small Lung Cancer

Unknown
NCT00016172Phase 1

ZD0473 and Doxorubicin in Treating Patients With Advanced Solid Tumors or Lymphoma

Completed
NCT00710697Phase 1

Cardiac Safety Assessment Study of Picoplatin in Solid Tumors

Unknown
NCT00465725Phase 1

A Study Comparing Oral Picoplatin With Intravenous Picoplatin in Subjects With Solid Tumors

Completed
NCT00465491Phase 3

Study of Picoplatin Efficacy After Relapse

Unknown
NCT00116610Phase 2

Picoplatin as Second-Line Therapy for Patients With Small Cell Lung Cancer

Completed
NCT00448734Phase 1

A Study of Picoplatin and Docetaxel in Subjects With Prostate Cancer

Unknown

All 7 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
7